IBDEI36D ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,53309,2)
 ;;=^5008765
 ;;^UTILITY(U,$J,358.3,53310,0)
 ;;=K64.4^^245^2679^17
 ;;^UTILITY(U,$J,358.3,53310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53310,1,3,0)
 ;;=3^Hemorrhoidal skin tags, residual
 ;;^UTILITY(U,$J,358.3,53310,1,4,0)
 ;;=4^K64.4
 ;;^UTILITY(U,$J,358.3,53310,2)
 ;;=^269834
 ;;^UTILITY(U,$J,358.3,53311,0)
 ;;=K64.8^^245^2679^18
 ;;^UTILITY(U,$J,358.3,53311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53311,1,3,0)
 ;;=3^Hemorrhoids, other
 ;;^UTILITY(U,$J,358.3,53311,1,4,0)
 ;;=4^K64.8
 ;;^UTILITY(U,$J,358.3,53311,2)
 ;;=^5008774
 ;;^UTILITY(U,$J,358.3,53312,0)
 ;;=K73.9^^245^2679^19
 ;;^UTILITY(U,$J,358.3,53312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53312,1,3,0)
 ;;=3^Hepatitis, chronic, unspec
 ;;^UTILITY(U,$J,358.3,53312,1,4,0)
 ;;=4^K73.9
 ;;^UTILITY(U,$J,358.3,53312,2)
 ;;=^5008815
 ;;^UTILITY(U,$J,358.3,53313,0)
 ;;=K74.60^^245^2679^1
 ;;^UTILITY(U,$J,358.3,53313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53313,1,3,0)
 ;;=3^Cirrhosis of liver, unspec
 ;;^UTILITY(U,$J,358.3,53313,1,4,0)
 ;;=4^K74.60
 ;;^UTILITY(U,$J,358.3,53313,2)
 ;;=^5008822
 ;;^UTILITY(U,$J,358.3,53314,0)
 ;;=K75.9^^245^2679^21
 ;;^UTILITY(U,$J,358.3,53314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53314,1,3,0)
 ;;=3^Inflammatory liver disease, unspecified
 ;;^UTILITY(U,$J,358.3,53314,1,4,0)
 ;;=4^K75.9
 ;;^UTILITY(U,$J,358.3,53314,2)
 ;;=^5008830
 ;;^UTILITY(U,$J,358.3,53315,0)
 ;;=K85.9^^245^2679^22
 ;;^UTILITY(U,$J,358.3,53315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53315,1,3,0)
 ;;=3^Pancreatitis, acute, unspec
 ;;^UTILITY(U,$J,358.3,53315,1,4,0)
 ;;=4^K85.9
 ;;^UTILITY(U,$J,358.3,53315,2)
 ;;=^5008887
 ;;^UTILITY(U,$J,358.3,53316,0)
 ;;=I69.959^^245^2680^9
 ;;^UTILITY(U,$J,358.3,53316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53316,1,3,0)
 ;;=3^Hemiplegia/Hemiparesis Following Unspec Cerebrovascular Disease
 ;;^UTILITY(U,$J,358.3,53316,1,4,0)
 ;;=4^I69.959
 ;;^UTILITY(U,$J,358.3,53316,2)
 ;;=^5007563
 ;;^UTILITY(U,$J,358.3,53317,0)
 ;;=I10.^^245^2680^8
 ;;^UTILITY(U,$J,358.3,53317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53317,1,3,0)
 ;;=3^HTN,Essential
 ;;^UTILITY(U,$J,358.3,53317,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,53317,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,53318,0)
 ;;=I20.9^^245^2680^1
 ;;^UTILITY(U,$J,358.3,53318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53318,1,3,0)
 ;;=3^Angina pectoris, unspecified
 ;;^UTILITY(U,$J,358.3,53318,1,4,0)
 ;;=4^I20.9
 ;;^UTILITY(U,$J,358.3,53318,2)
 ;;=^5007079
 ;;^UTILITY(U,$J,358.3,53319,0)
 ;;=I21.3^^245^2680^11
 ;;^UTILITY(U,$J,358.3,53319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53319,1,3,0)
 ;;=3^Myocardial infarctions (STEMI), unspec site
 ;;^UTILITY(U,$J,358.3,53319,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,53319,2)
 ;;=^5007087
 ;;^UTILITY(U,$J,358.3,53320,0)
 ;;=I25.10^^245^2680^2
 ;;^UTILITY(U,$J,358.3,53320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53320,1,3,0)
 ;;=3^Athscl hrt disease w/o angina pectoris
 ;;^UTILITY(U,$J,358.3,53320,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,53320,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,53321,0)
 ;;=I25.2^^245^2680^15
 ;;^UTILITY(U,$J,358.3,53321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53321,1,3,0)
 ;;=3^Old myocardial infarction
 ;;^UTILITY(U,$J,358.3,53321,1,4,0)
 ;;=4^I25.2
 ;;^UTILITY(U,$J,358.3,53321,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,53322,0)
 ;;=I30.0^^245^2680^10
 ;;^UTILITY(U,$J,358.3,53322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53322,1,3,0)
 ;;=3^Idiopathic pericarditis, acute
 ;;^UTILITY(U,$J,358.3,53322,1,4,0)
 ;;=4^I30.0
 ;;^UTILITY(U,$J,358.3,53322,2)
 ;;=^5007157
